சோதனை உயிரியல் மற்றும் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சோதனை உயிரியல் மற்றும் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சோதனை உயிரியல் மற்றும் மருந்து Today - Breaking & Trending Today

A New microRNA Target for Treating Spinal Cord Injuries

A New microRNA Target for Treating Spinal Cord Injuries
News provided by
Share this article
WASHINGTON, June 9, 2021 /PRNewswire/ An article published in
Experimental Biology and Medicine (Volume 246, Issue 11, June 2021) describes a new target for treating spinal cord injuries. The study, led by Dr. Chunfang Wang, in the Shanxi Key Laboratory of Animal and Animal Model of Human Diseases at Shanxi Medical University in Taiyuan (China), reports that modulating the expression of a specific microRNA improves motor function in a mouse model of spinal cord injury.
Damage to the spinal cord results in changes in strength, sensation and other body functions below the site of the injury. Restoring motor function is a key factor in managing spinal cord injury. Injection of neural stems has been shown to be effective, but the availability of neural cells is limited by ethical and practical issues. Another option is stimulating the proliferation of undifferentiat ....

United States , Stevenr Goodman , Chunfang Wang , Society Of Experimental Biology , Shanxi Key Laboratory Of Animal , Experimental Biology , Shanxi Key Laboratory , Animal Model , Human Diseases , Shanxi Medical University , Experimental Biology And Medicine , ஒன்றுபட்டது மாநிலங்களில் , சமூகம் ஆஃப் சோதனை உயிரியல் , சோதனை உயிரியல் , விலங்கு மாதிரி , மனிதன் நோய்கள் , சோதனை உயிரியல் மற்றும் மருந்து ,

Advances in Nucleic-Based Therapeutics

Share this article
WASHINGTON, March 16, 2021 /PRNewswire/ An article published in
Experimental Biology and Medicine (Volume 246, Issue 6, March, 2021) reports a new nucleic acid-based approach for therapeutics targeting inflammation. The study, led by Dr. Anthony Bell Jr, in the Department of Chemistry and Biochemistry at the University of San Diego in San Diego, CA (USA), reports four novel cruciform DNA ligands that exhibit increased nuclease-resistance, thermostability, and target-binding affinity.
HMGB1 (High Mobility Group B1) is an important molecular target in multiple human diseases including infectious diseases, ischemia, immune disorders, neurodegenerative diseases, metabolic disorders, and cancer. HMGB1 plays two different but critical roles inside and outside of cells. Inside cells, HMGB1 bends DNA into arrangements or scaffolds that facilitate gene expression. Outside cells, HMGB1 functions as a proinflammatory cytokine that can be either a fri ....

San Diego , United States , University Of San Diego , Stevenr Goodman , Anthony Bell Jr , Department Of Chemistry , Society Of Experimental Biology , High Mobility Group , Experimental Biology , Experimental Biology And Medicine , சான் டியாகோ , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் சான் டியாகோ , அந்தோணி மணி ஜூனியர் , துறை ஆஃப் வேதியியல் , சமூகம் ஆஃப் சோதனை உயிரியல் , உயர் இயக்கம் குழு , சோதனை உயிரியல் , சோதனை உயிரியல் மற்றும் மருந்து ,

Maintaining Heart Function After a Heart Attack

Maintaining Heart Function After a Heart Attack
News provided by
Share this article
WASHINGTON, March 4, 2021 /PRNewswire/ An article published in
Experimental Biology and Medicine (Volume 246, Issue 5, March, 2021) (https://journals.sagepub.com/doi/pdf/10.1177/1535370220969844) reports a new therapeutic option for preventing long-term damage to the heart after a heart attack. The study, led by Dr. Y. James Kang, in the Regenerative Medicine Research Center at Sichuan University in Chengdu (China) and the Memphis Institute of Regenerative Medicine at the University of Tennessee Health Science Center in Memphis, TN (USA), reports that inhibition of the copper chaperone COMMD1 blocks myocardial injury and maintains heart function in a mouse model of myocardial ischemia. ....

United States , Stevenr Goodman , Y James Kang , Society Of Experimental Biology , University Of Tennessee Health Science Center , Memphis Institute Of Regenerative Medicine , Regenerative Medicine Research Center At Sichuan University , Experimental Biology , Regenerative Medicine Research Center , Sichuan University , Memphis Institute , Regenerative Medicine , Tennessee Health Science Center , Experimental Biology And Medicine , Stem Science , Computer Amp Electronics , Medical Pharmaceuticals , Health Care Amp Hospitals , Publishing Amp Information Services , Polls And Research , Clinical Trials Amp Medical Discoveries , ஒன்றுபட்டது மாநிலங்களில் , ய் ஜேம்ஸ் காங் , சமூகம் ஆஃப் சோதனை உயிரியல் , பல்கலைக்கழகம் ஆஃப் டென்னசி ஆரோக்கியம் அறிவியல் மையம் , மெம்பிஸ் நிறுவனம் ஆஃப் மீளுருவாக்கம் மருந்து ,